These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2277141)

  • 81. Quantity, distribution and immunophenotypical modification of dendritic cells upon biological treatments in psoriasis.
    Prignano F; Ricceri F; Bianchi B; Lotti T
    Int J Immunopathol Pharmacol; 2009; 22(2):379-87. PubMed ID: 19505376
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis.
    Nickoloff BJ; Karabin GD; Barker JN; Griffiths CE; Sarma V; Mitra RS; Elder JT; Kunkel SL; Dixit VM
    Am J Pathol; 1991 Jan; 138(1):129-40. PubMed ID: 1702929
    [TBL] [Abstract][Full Text] [Related]  

  • 83. T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells.
    Vollmer S; Menssen A; Trommler P; Schendel D; Prinz JC
    Eur J Immunol; 1994 Oct; 24(10):2377-82. PubMed ID: 7925564
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The role of immune system in the pathogenesis of psoriasis.
    Baadsgaard O; Fisher G; Voorhees JJ; Cooper KD
    J Invest Dermatol; 1990 Nov; 95(5 Suppl):32S-34S. PubMed ID: 16788627
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Epidermal dendritic cells in psoriasis possess a phenotype associated with antigen presentation: in situ expression of beta 2-integrins.
    McGregor JM; Barker JN; Ross EL; MacDonald DM
    J Am Acad Dermatol; 1992 Sep; 27(3):383-8. PubMed ID: 1401271
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Inhibitory activity of cyclosporine is dependent on the activating signal(s) provided to T cells.
    Suthanthiran M
    J Pediatr; 1987 Dec; 111(6 Pt 2):1008-11. PubMed ID: 2960793
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Treatment of resistant severe psoriasis with systemic cyclosporine.
    Picascia DD; Garden JM; Freinkel RK; Roenigk HH
    J Am Acad Dermatol; 1987 Sep; 17(3):408-14. PubMed ID: 3655020
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Effect of cyclosporine A on the regulation of Ia antigen keratinocytes expression.
    Gilhar A; Etzioni A; Pillar T; Assy B; Eidelman S
    Clin Immunol Immunopathol; 1991 Sep; 60(3):349-55. PubMed ID: 1650656
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The immunopathology of psoriasis.
    Barker JN
    Baillieres Clin Rheumatol; 1994 May; 8(2):429-38. PubMed ID: 8076396
    [TBL] [Abstract][Full Text] [Related]  

  • 90. NF-kappaB links keratinocytes and lymphocytes in the pathogenesis of psoriasis.
    Tsuruta D
    Recent Pat Inflamm Allergy Drug Discov; 2009 Jan; 3(1):40-8. PubMed ID: 19149745
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Effects of chloroquine on antigen-presenting functions of epidermal cells from normal and psoriatic skin.
    Demidem A; Taylor JR; Grammer SF; Streilein JW
    J Invest Dermatol; 1992 Feb; 98(2):181-6. PubMed ID: 1732381
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Immunopathogenesis of psoriasis.
    Sanchez AP
    An Bras Dermatol; 2010; 85(5):747-9. PubMed ID: 21152809
    [TBL] [Abstract][Full Text] [Related]  

  • 93. T lymphocytes in psoriasis.
    Prens E; Debets R; Hegmans J
    Clin Dermatol; 1995; 13(2):115-29. PubMed ID: 7780914
    [No Abstract]   [Full Text] [Related]  

  • 94. Acrodermatitis continua-type of pustular psoriasis responds to low-dose cyclosporine.
    Peter RU; Ruzicka T; Donhauser G; Braun-Falco O
    J Am Acad Dermatol; 1990 Sep; 23(3 Pt 1):515-6. PubMed ID: 2212157
    [No Abstract]   [Full Text] [Related]  

  • 95. Inhibition of a Langerhans cell-mediated immune response by treatment modalities useful in psoriasis.
    Morhenn VB; Orenberg EK; Kaplan J; Pfendt E; Terrell C; Engleman EG
    J Invest Dermatol; 1983 Jul; 81(1):23-7. PubMed ID: 6863976
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Effects of Sandimmun on T lymphocyte and dendritic cell subpopulations in psoriasis.
    Baker BS; Fry L; Powles AV
    Arch Dermatol Res; 1990; 282(5):351-2. PubMed ID: 2221988
    [No Abstract]   [Full Text] [Related]  

  • 97. Systemic and local administration of cyclosporine in the treatment of psoriasis.
    Griffiths CE
    J Am Acad Dermatol; 1990 Dec; 23(6 Pt 2):1242-6; discussion 1246-7. PubMed ID: 2277131
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The role of T cells in psoriasis.
    Prinz JC
    J Eur Acad Dermatol Venereol; 2003 May; 17(3):257-70. PubMed ID: 12702062
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Cyclosporine. An immunosuppressant affecting epithelial cell proliferation.
    Kanitakis J; Thivolet J
    Arch Dermatol; 1990 Mar; 126(3):369-75. PubMed ID: 2178559
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Lymphocytic infiltrates of the skin in association with cyclosporine therapy.
    Gupta AK; Cooper KD; Ellis CN; Nickoloff BJ; Hanson CA; Brown MD; Voorhees JJ
    J Am Acad Dermatol; 1990 Dec; 23(6 Pt 1):1137-41. PubMed ID: 2273115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.